Randy Milby - 14 Jan 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
14 Jan 2022
Net transactions value
+$83,714
Form type
4
Filing time
20 Jan 2022, 08:23:48 UTC
Previous filing
20 Jan 2022
Next filing
19 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Conversion of derivative security $87,933 +27,479 +1.6% $3.20* 1,800,204 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $98,470 +30,772 +1.7% $3.20* 1,830,976 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $2,170 +678 +0.04% $3.20* 1,831,654 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $32,589 +10,184 +0.56% $3.20* 1,841,838 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $59,638 +18,637 +1% $3.20* 1,860,475 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $59,629 +18,634 +1% $3.20* 1,879,109 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $43,232 +13,510 +0.72% $3.20* 1,892,619 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $43,110 +13,472 +0.71% $3.20* 1,906,091 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $43,011 +13,441 +0.71% $3.20* 1,919,532 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $53,622 +16,757 +0.87% $3.20* 1,936,289 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $32,058 +10,018 +0.52% $3.20* 1,946,307 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $37,299 +11,656 +0.6% $3.20* 1,957,963 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $583,840 +182,450 +9.3% $3.20* 2,140,413 14 Jan 2022 Direct
transaction HILS Common Stock Conversion of derivative security $53,238 +16,637 +0.78% $3.20* 2,157,050 14 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HILS Convertible Note Conversion of derivative security $80,000 0 14 Jan 2022 Common stock 27,479 $3.20 Direct F1
transaction HILS Convertible Note Conversion of derivative security $90,000 0 14 Jan 2022 Common stock 30,772 $3.20 Direct F2
transaction HILS Convertible Note Conversion of derivative security $2,000 0 14 Jan 2022 Common stock 678 $3.20 Direct F3
transaction HILS Convertible Note Conversion of derivative security $30,000 0 14 Jan 2022 Common stock 10,184 $3.20 Direct F4
transaction HILS Convertible Note Conversion of derivative security $55,000 0 14 Jan 2022 Common stock 18,637 $3.20 Direct F5
transaction HILS Convertible Note Conversion of derivative security $55,068 0 14 Jan 2022 Common stock 18,634 $3.20 Direct F6
transaction HILS Convertible Note Conversion of derivative security $40,000 0 14 Jan 2022 Common stock 13,510 $3.20 Direct F7
transaction HILS Convertible Note Conversion of derivative security $40,000 0 14 Jan 2022 Common stock 13,472 $3.20 Direct F8
transaction HILS Convertible Note Conversion of derivative security $40,000 0 14 Jan 2022 Common stock 13,441 $3.20 Direct F9
transaction HILS Convertible Note Conversion of derivative security $50,000 0 14 Jan 2022 Common stock 16,757 $3.20 Direct F10
transaction HILS Convertible Note Conversion of derivative security $30,000 0 14 Jan 2022 Common stock 10,018 $3.20 Direct F11
transaction HILS Convertible Note Conversion of derivative security $35,000 0 14 Jan 2022 Common stock 11,656 $3.20 Direct F12
transaction HILS Convertible Note Conversion of derivative security $549,058 0 14 Jan 2022 Common stock 182,450 $3.20 Direct F13
transaction HILS Convertible Note Conversion of derivative security $50,000 0 14 Jan 2022 Common stock 16,637 $3.20 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 21, 2020, the Registrant issued the Reporting Person an $80,000 note which matures on the earlier of (i) January 20, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F2 On February 27, 2020, the Registrant issued the Reporting Person a $90,000 note which matures on the earlier of (i) February 26, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F3 On April 23, 2020, the Registrant issued the Reporting Person a $2,000 note which matures on the earlier of (i) April 23, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F4 On April 24, 2020, the Registrant issued the Reporting Person a $30,000 note which matures on the earlier of (i) April 24, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F5 On May 8, 2020, the Registrant issued the Reporting Person a $55,000 note which matures on the earlier of (i) May 8, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F6 On May 19, 2020, the Registrant issued the Reporting Person a $55,068 note which matures on the earlier of (i) May 19, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F7 On June 3, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) June 3, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F8 On June 25, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) June 25, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F9 On July 13, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) July 13, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F10 On August 3, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) August 3, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F11 On August 31, 2020, the Registrant issued the Reporting Person a $30,000 note which matures on the earlier of (i) August 31, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F12 On September 21, 2020, the Registrant issued the Reporting Person a $35,000 note which matures on the earlier of (i) September 21, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F13 On September 27, 2020, the Registrant issued the Reporting Person notes in the aggregate principal amount of $549,058.09. The notes mature on the earlier of (i) September 27, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the notes together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F14 On September 28, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) September 28, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.

Remarks:

This is the first of the Form 4s.